Cytomegalovirus pneumonitis, activated prothrombin time prolongation and subacute thyroiditis after unrelated allogeneic bone marrow transplantation

被引：3
|
作者：
Kawano, C
Muroi, K [1 ]
Akioka, T
Izumi, T
Kodera, Y
Ozawa, K
机构：
[1] Jichi Med Sch, Div Cell Transplantat & Transfus, Minami Kawachi, Tochigi 3290498, Japan
[2] Jichi Med Sch, Dept Hematol, Minami Kawachi, Tochigi 3290498, Japan
[3] Japanese Red Cross 1st Hosp, Dept Internal Med, Div Hematol, Nagoya, Aichi, Japan
来源：
BONE MARROW TRANSPLANTATION | 2000年 / 26卷 / 12期
关键词：
bone marrow transplantation; antithymocyte globulin; viral infection; CD4(+) cells;
D O I：
10.1038/sj.bmt.1702711
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
A 22-year-old female with acute myeloid leukemia (AML) in complete remission received a conditioning regimen containing antithymocyte globulin for an unrelated bone marrow transplant (BMT). After BMT, the patient suffered from cytomegalovirus (CMV) pneumonitis with markedly high levels of CMV antigenemia, activated prothrombin time (APTT) prolongation, and subacute thyroiditis. Recovery of CD4(+) cells was delayed as long as 1 year after BMT, An association between these three episodes and viral infection due to the delayed recovery of CD4(+) cells is suggested.
引用
收藏
页码：1347 / 1349
页数：3
相关论文
共 50 条
  • [31] INTERSTITIAL PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION
    VAREKAMP, AE
    DEVRIES, A
    ZURCHER, C
    HAGENBEEK, A
    LEUKEMIA RESEARCH, 1986, 10 (01) : 121 - 121
  • [32] DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV) PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHROEDER, M
    ESSELL, J
    HARMAN, G
    HALVORSON, R
    DOLAN, M
    CALLANDER, N
    SNYDER, M
    WILKS, S
    ALLERTON, J
    THOMPSON, J
    BLOOD, 1993, 82 (10) : A425 - A425
  • [33] Bone marrow engraftment analysis after allogeneic bone marrow transplantation
    Van Deerlin, VMD
    Leonard, DGB
    CLINICS IN LABORATORY MEDICINE, 2000, 20 (01) : 197 - +
  • [34] RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNRELATED OR MISMATCHED DONORS
    BEATTY, PG
    SEMINARS IN ONCOLOGY, 1992, 19 (03) : 13 - 19
  • [35] Osteonecrosis after allogeneic bone marrow transplantation
    Zadegan, Frederic
    Raould, Agnes
    Bizot, Pascal
    Nizard, Remy
    Sedel, Laurent
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2008, 466 (02) : 287 - 293
  • [36] Thyrotoxicosis after allogeneic bone marrow transplantation
    Robaday, S
    Stamatoullas, A
    Contentin, N
    Lenain, P
    Lepretre, S
    Tilly, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S214 - S214
  • [37] Hyposplenism after allogeneic bone marrow transplantation
    Au, WY
    Ma, SK
    Wong, KK
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 488 - 488
  • [38] IN-SITU HYBRIDIZATION FOR THE DETECTION OF CYTOMEGALOVIRUS IN BLOOD OR BONE-MARROW LEUKOCYTES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FEST, T
    DESCHASEAUX, M
    MOUGIN, C
    CAHN, JY
    DUPOND, JL
    HERVE, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (03) : 619 - 623
  • [39] Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
    Szer, J
    Durrant, S
    Schwarer, AP
    Bradstock, KF
    Gibson, J
    Arthur, C
    To, LB
    Hughes, T
    Raunow, H
    INTERNAL MEDICINE JOURNAL, 2004, 34 (03) : 98 - 101
  • [40] EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GOODRICH, JM
    MORI, M
    GLEAVES, CA
    DUMOND, C
    CAYS, M
    EBELING, DF
    BUHLES, WC
    DEARMOND, B
    MEYERS, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23): : 1601 - 1607
12345